Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Adenocarcinoma of Lung"" wg kryterium: Temat


Tytuł:
DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target.
Autorzy:
Chen M; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, People's Republic of China.
Zhang S; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Wang F; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
He J; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Jiang W; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, People's Republic of China. .
Zhang L; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Feb 27; Vol. 22 (1), pp. 209. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Urea*/analogs & derivatives
Humans ; Benzimidazoles ; Neoplasm Proteins ; Prognosis
Czasopismo naukowe
Tytuł:
The value of CT shape quantification in predicting pathological classification of lung adenocarcinoma.
Autorzy:
Guo M; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
Cao Z; Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, 450000, Zhengzhou, China.
Huang Z; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
Hu S; Department of Clinical Medicine, Medical School of Henan University, Kaifeng, China.
Xiao Y; Department of Clinical Medicine, Medical School of Henan University, Kaifeng, China.
Ding Q; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
Liu Y; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
An X; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
Zheng X; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
Zhang S; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China.
Zhang G; Department of Thoracic Surgery, The First Affiliated Hospital of Henan University, Longting District, 475000, Kaifeng, Henan Province, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 04; Vol. 24 (1), pp. 35. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/pathology
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/pathology
Humans ; Tomography, X-Ray Computed/methods ; Neoplasm Invasiveness ; Retrospective Studies
Czasopismo naukowe
Tytuł:
DIEANet: an attention model for histopathological image grading of lung adenocarcinoma based on dimensional information embedding.
Autorzy:
Wang Z; College of Software, Xinjiang University, Urumqi, 830046, China.
Gao J; Xinjiang Key Laboratory of Clinical Genetic Testing and Biomedical Information, Karamay, 834099, China.; Xinjiang Clinical Research Center for Precision Medicine of Digestive System Tumor, Karamay, 834099, China.; Department of Pathology, Karamay Central Hospital, Karamay, 834099, China.
Li M; College of Information Science and Engineering, Xinjiang University, Urumqi, 830046, China.; Key Laboratory of Signal Detection and Processing, Xinjiang University, Urumqi, 830046, China.
Zuo E; College of Information Science and Engineering, Xinjiang University, Urumqi, 830046, China.; Xinjiang Cloud Computing Application Laboratory, Karamay, 834099, China.
Chen C; College of Information Science and Engineering, Xinjiang University, Urumqi, 830046, China.; Xinjiang Cloud Computing Application Laboratory, Karamay, 834099, China.
Chen C; College of Software, Xinjiang University, Urumqi, 830046, China.
Liang F; Xinjiang Key Laboratory of Clinical Genetic Testing and Biomedical Information, Karamay, 834099, China.; Xinjiang Clinical Research Center for Precision Medicine of Digestive System Tumor, Karamay, 834099, China.; Department of Pathology, Karamay Central Hospital, Karamay, 834099, China.
Lv X; College of Software, Xinjiang University, Urumqi, 830046, China. .; College of Information Science and Engineering, Xinjiang University, Urumqi, 830046, China. .; Key Laboratory of Signal Detection and Processing, Xinjiang University, Urumqi, 830046, China. .; Xinjiang Cloud Computing Application Laboratory, Karamay, 834099, China. .
Ma Y; Xinjiang Key Laboratory of Clinical Genetic Testing and Biomedical Information, Karamay, 834099, China. .; Xinjiang Clinical Research Center for Precision Medicine of Digestive System Tumor, Karamay, 834099, China. .; Department of Pathology, Karamay Central Hospital, Karamay, 834099, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 14; Vol. 14 (1), pp. 6209. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*
Adenocarcinoma*
Data Compression*
Lung Neoplasms*/diagnosis
Humans ; Benchmarking
Czasopismo naukowe
Tytuł:
Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less KRAS and More EGFR Mutations Compared to Advanced Adenocarcinomas.
Autorzy:
Petterson J; Department of Clinical Pathology, Sahlgrenska University Hospital, Västra Götalandsregionen, 413 45 Gothenburg, Sweden.
Mustafa D; Department of Medical Chemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.
Bandaru S; Department of Clinical Pathology, Sahlgrenska University Hospital, Västra Götalandsregionen, 413 45 Gothenburg, Sweden.
Eklund EÄ; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.; Department of Clinical Oncology, Sahlgrenska University Hospital, Västra Götalandsregionen, 413 45 Gothenburg, Sweden.
Hallqvist A; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.; Department of Clinical Oncology, Sahlgrenska University Hospital, Västra Götalandsregionen, 413 45 Gothenburg, Sweden.
Sayin VI; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.; Department of Surgery, Institute of Clinical Sciences, University of Gothenburg, 413 45 Gothenburg, Sweden.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, 413 45 Gothenburg, Sweden.
Gagné A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Fagman H; Department of Clinical Pathology, Sahlgrenska University Hospital, Västra Götalandsregionen, 413 45 Gothenburg, Sweden.; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.; Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.
Akyürek LM; Department of Clinical Pathology, Sahlgrenska University Hospital, Västra Götalandsregionen, 413 45 Gothenburg, Sweden.; Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 03; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 03.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma in Situ*/genetics
Adenocarcinoma in Situ*/pathology
Adenocarcinoma of Lung*/genetics
Adenocarcinoma*/pathology
Lung Neoplasms*/metabolism
Humans ; Proto-Oncogene Proteins p21(ras)/genetics ; Mutation ; ErbB Receptors/metabolism
Czasopismo naukowe
Tytuł:
Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system.
Autorzy:
Wang S; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li Y; Ping An Healthcare Technology, Beijing, China.
Sun X; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Dong J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department of Pathology, the 5th Affiliated Hospital of Qiqihar Medical College/Longnan Hospital, Daqing, China.
Chen R; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li F; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chen T; Ping An Healthcare Technology, Beijing, China.
Li X; Ping An Healthcare Technology, Beijing, China.
Xie G; Ping An Healthcare Technology, Beijing, China.; Ping An Health Cloud Company Limited, Beijing, China.; Ping An International Smart City Technology Co, Beijing, China.
Ying J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guo Q; Big data office, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Mao Y; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yang L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (7), pp. 519-528. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/pathology
Humans ; Retrospective Studies ; Reproducibility of Results ; Neoplasm Staging ; Prognosis
Czasopismo naukowe
Tytuł:
With regard to the original article "A case of primary lung adenocarcinoma mimicking metastatic papillary thyroid carcinoma".
Autorzy:
Hanamatsu Y; Department of Pathology and Translational Study, Gifu University School of Medicine, Gifu, Japan.; One Medicine Center for Innovative Translational Research; Center for One Medicine Innovative Translational Research, Gifu University, Gifu, Japan.
Yada Y; Department of General Thoracic Surgery, Gifu University Hospital, Gifu, Japan.
Shirahashi K; Department of General Thoracic Surgery, Gifu University Hospital, Gifu, Japan.
Takeuchi T; Department of Pathology and Translational Study, Gifu University School of Medicine, Gifu, Japan.; One Medicine Center for Innovative Translational Research; Center for One Medicine Innovative Translational Research, Gifu University, Gifu, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (5), pp. 434-435. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Adenocarcinoma of Lung*/diagnosis
Adenocarcinoma*/pathology
Thyroid Neoplasms*/pathology
Lung Neoplasms*/pathology
Humans ; Thyroid Cancer, Papillary/diagnosis
Raport
Tytuł:
TPI1 promotes MAPK/ERK-induced EMT, cell migration and invasion in lung adenocarcinoma.
Autorzy:
Li Y; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Pan B; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Department of Cardiothoracic Surgery, People's Hospital Affiliated to Jiangsu University, Zhenjiang, China.
Zhang F; Soochow University Medical College, Suzhou, China.
Jia X; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhu X; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Tong X; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Zhao J; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Li C; Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (4), pp. 327-338. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Humans ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Epithelial-Mesenchymal Transition ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
The role of adenocarcinoma subtypes and immunohistochemistry in predicting lymph node metastasis in early invasive lung adenocarcinoma.
Autorzy:
Xue M; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China.
Liu J; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China.
Li Z; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China.
Lu M; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China.
Zhang H; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China.
Liu W; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China.
Tian H; Department of Thoracic Surgery, Qilu Hospital, Shandong University, Lixia District, Jinan City, Shandong Province, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 29; Vol. 24 (1), pp. 139. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/surgery
Adenocarcinoma of Lung*
Lung Neoplasms*
Humans ; Immunohistochemistry ; Lymphatic Metastasis ; Nomograms ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes.
Autorzy:
Zhou F; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Wang M; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Wang Z; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Li W; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
Lu X; Department of Thoracic Surgery, Tianjin Chest Hospital of Tianjin University, 261 Taierzhuang South Road, Jinnan District, Tianjin, 300222, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Jan 02; Vol. 24 (1), pp. 28. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Adenocarcinoma*/genetics
Lung Neoplasms*/genetics
Humans ; mRNA Vaccines ; NLR Family, Pyrin Domain-Containing 3 Protein ; Pyroptosis/genetics ; DNA Copy Number Variations ; Phenotype ; Antigens, Neoplasm/genetics ; Prognosis ; Tumor Microenvironment ; Neoplasm Proteins ; CARD Signaling Adaptor Proteins
Czasopismo naukowe
Tytuł:
Multi-classification model incorporating radiomics and clinic-radiological features for predicting invasiveness and differentiation of pulmonary adenocarcinoma nodules.
Autorzy:
Sun H; Medical Imaging Center, Central Hospital Affiliated to Shandong First Medical University, 105 Jiefang Road, Lixia District, Jinan, 250013, Shandong Province, China.
Zhang C; Medical Imaging Center, Central Hospital Affiliated to Shandong First Medical University, 105 Jiefang Road, Lixia District, Jinan, 250013, Shandong Province, China.
Ouyang A; Medical Imaging Center, Central Hospital Affiliated to Shandong First Medical University, 105 Jiefang Road, Lixia District, Jinan, 250013, Shandong Province, China.
Dai Z; Scientific Research Department of Huiying Medical Technology Co., Ltd, 66 Xixiaokou Road, Haidian District, Beijing, 100192, China.
Song P; Medical Imaging Center, Central Hospital Affiliated to Shandong First Medical University, 105 Jiefang Road, Lixia District, Jinan, 250013, Shandong Province, China.
Yao J; Medical Imaging Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Huaiyin District, Jinan, 250021, Shandong Province, China. .
Pokaż więcej
Źródło:
Biomedical engineering online [Biomed Eng Online] 2023 Nov 30; Vol. 22 (1), pp. 112. Date of Electronic Publication: 2023 Nov 30.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/pathology
Adenocarcinoma of Lung*/surgery
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/pathology
Multiple Pulmonary Nodules*/pathology
Humans ; Retrospective Studies ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł:
An individualized nomogram for predicting and validating spread through air space (STAS) in surgically resected lung adenocarcinoma: a single center retrospective analysis.
Autorzy:
Wang J; Department of Thoracic Surgery, Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital Affiliated to Fudan University, Shanghai, 200041, China.
Yao Y; Department of Thoracic Surgery, Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital Affiliated to Fudan University, Shanghai, 200041, China.
Tang D; Department of Thoracic Surgery, Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital Affiliated to Fudan University, Shanghai, 200041, China.
Gao W; Department of Thoracic Surgery, Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital Affiliated to Fudan University, Shanghai, 200041, China. .
Pokaż więcej
Źródło:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2023 Nov 21; Vol. 18 (1), pp. 337. Date of Electronic Publication: 2023 Nov 21.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/surgery
Adenocarcinoma of Lung*/pathology
Adenocarcinoma*/surgery
Adenocarcinoma*/pathology
Embolism*
Humans ; Retrospective Studies ; Nomograms ; B7-H1 Antigen ; Ki-67 Antigen ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Circular RNA P4HB promotes glycolysis and tumor progression by binding with PKM2 in lung adenocarcinoma.
Autorzy:
Li H; Department of Thoracic Surgery, Peking University People's Hospital, No. 11 Xizhimen South Street, Beijing, 100044, China.; Thoracic Oncology Institute, Peking University People's Hospital, Beijing, 100044, China.
Guo H; The First Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China.
Huang Q; Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450003, China.
Wang S; Department of Thoracic Surgery, Peking University People's Hospital, No. 11 Xizhimen South Street, Beijing, 100044, China.; Thoracic Oncology Institute, Peking University People's Hospital, Beijing, 100044, China.
Li X; Department of Thoracic Surgery, Peking University People's Hospital, No. 11 Xizhimen South Street, Beijing, 100044, China.; Thoracic Oncology Institute, Peking University People's Hospital, Beijing, 100044, China.
Qiu M; Department of Thoracic Surgery, Peking University People's Hospital, No. 11 Xizhimen South Street, Beijing, 100044, China. .; Thoracic Oncology Institute, Peking University People's Hospital, Beijing, 100044, China. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2023 Oct 25; Vol. 24 (1), pp. 252. Date of Electronic Publication: 2023 Oct 25.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/genetics
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/metabolism
MicroRNAs*/genetics
RNA, Circular*/genetics
Humans ; Cell Line, Tumor ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Glucose ; Glycolysis/genetics ; Lactates ; Procollagen-Proline Dioxygenase/genetics ; Procollagen-Proline Dioxygenase/metabolism ; Protein Disulfide-Isomerases/genetics ; Protein Disulfide-Isomerases/metabolism ; Thyroid Hormone-Binding Proteins
Czasopismo naukowe
Tytuł:
Therapeutic impact of epidermal growth factor receptor tyrosine kinase inhibitor with various treatment combinations for advanced lung adenocarcinoma.
Autorzy:
Chen YY; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China. .; Graduate Institute of Medical Science, National Defense Medical Center, Taipei, Republic of China. .
Lin KH; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China.
Kuo YS; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China.; Graduate Institute of Medical Science, National Defense Medical Center, Taipei, Republic of China.
Tsai YM; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China.
Huang HK; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China.
Huang TW; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China.; Graduate Institute of Medical Science, National Defense Medical Center, Taipei, Republic of China.
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2023 Oct 13; Vol. 21 (1), pp. 326. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/drug therapy
Adenocarcinoma*/genetics
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Tyrosine Kinase Inhibitors ; Retrospective Studies ; Protein Kinase Inhibitors/therapeutic use ; ErbB Receptors/genetics ; Mutation
Czasopismo naukowe
Tytuł:
PB-LNet: a model for predicting pathological subtypes of pulmonary nodules on CT images.
Autorzy:
Zhang Y; Department of Medical Oncology, the First Hospital of China Medical University, NO.155, North Nanjing Street, Heping District, Shenyang, Liaoning Province, 110001, China.
Qu H; College of Medicine and Biological Information Engineering, Northeastern University, NO. 3-11, Wenhua Road, Heping District, Shenyang, 110819, Liaoning Province, China.
Tian Y; Department of Medical Oncology, the First Hospital of China Medical University, NO.155, North Nanjing Street, Heping District, Shenyang, Liaoning Province, 110001, China.
Na F; Network Information Center, China Medical University, NO.77 Puhe Road, Shenbei New District, Shenyang, Liaoning Province, 110122, China.
Yan J; Department of Medical Oncology, the First Hospital of China Medical University, NO.155, North Nanjing Street, Heping District, Shenyang, Liaoning Province, 110001, China.
Wu Y; Phase I Clinical Trails Center, the First Hospital of China Medical University, 210 1st Baita Street, Hunnan Distriction, Shenyang, Liaoning Province, 110101, China.
Cui X; College of Medicine and Biological Information Engineering, Northeastern University, NO. 3-11, Wenhua Road, Heping District, Shenyang, 110819, Liaoning Province, China. .; Key Laboratory of Intelligent Computing in Medical Image, Ministry of Education, Shenyang, China. .
Li Z; Department of Medical Oncology, the First Hospital of China Medical University, NO.155, North Nanjing Street, Heping District, Shenyang, Liaoning Province, 110001, China. .
Zhao M; Department of Medical Oncology, the First Hospital of China Medical University, NO.155, North Nanjing Street, Heping District, Shenyang, Liaoning Province, 110001, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Oct 03; Vol. 23 (1), pp. 936. Date of Electronic Publication: 2023 Oct 03.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/pathology
Multiple Pulmonary Nodules*/diagnostic imaging
Adenocarcinoma*
Humans ; Tomography, X-Ray Computed/methods ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Lymph node metastasis and its risk factors in T1 lung adenocarcinoma.
Autorzy:
Zhang W; Department of Thoracic Surgery, Jiangsu Province Hospital and The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Mu G; Department of Thoracic Surgery, Jiangsu Province Hospital and The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Huang J; Department of Thoracic Surgery, Jiangsu Province Hospital and The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Bian C; Department of Thoracic Surgery, Jiangsu Province Hospital and The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wang H; Department of Thoracic Surgery, Jiangsu Province Hospital and The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Gu Y; Department of Thoracic Surgery, Jiangsu Province Hospital and The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xia Y; Department of Thoracic Surgery, Jiangsu Province Hospital and The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Chen L; Department of Thoracic Surgery, Jiangsu Province Hospital and The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yuan M; Department of Radiology, Jiangsu Province Hospital and The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wang J; Department of Thoracic Surgery, Jiangsu Province Hospital and The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Oct; Vol. 14 (30), pp. 2993-3000. Date of Electronic Publication: 2023 Sep 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lung Neoplasms*/pathology
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/surgery
Adenocarcinoma of Lung*/pathology
Humans ; Lymphatic Metastasis ; Retrospective Studies ; Prognosis ; Lymph Node Excision ; Risk Factors ; Neoplasm Staging
Czasopismo naukowe
Tytuł:
Lung adenocarcinoma with micropapillary and solid patterns: Recurrence rate and trends.
Autorzy:
Takeno N; Department of Thoracic Surgery, Keiyukai Sapporo Hospital, Sapporo, Japan.
Tarumi S; Department of Thoracic Surgery, Keiyukai Sapporo Hospital, Sapporo, Japan.
Abe M; Department of Thoracic Surgery, Keiyukai Sapporo Hospital, Sapporo, Japan.
Suzuki Y; Department of Thoracic Surgery, Keiyukai Sapporo Hospital, Sapporo, Japan.
Kinoshita I; Department of Medical Oncology, Hokkaido University, Sapporo, Japan.
Kato T; Department of Thoracic Surgery, Hokkaido University, Sapporo, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Oct; Vol. 14 (30), pp. 2987-2992. Date of Electronic Publication: 2023 Sep 02.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Adenocarcinoma*/genetics
Adenocarcinoma*/surgery
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/surgery
Humans ; B7-H1 Antigen ; Neoplasm Staging ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
DARS2 promotes the occurrence of lung adenocarcinoma via the ERK/c-Myc signaling pathway.
Autorzy:
Fang T; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, China.
Jiang J; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, China.
Yu W; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, China.
Li R; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, China.
Tian H; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Dec; Vol. 14 (36), pp. 3511-3521. Date of Electronic Publication: 2023 Nov 11.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/pathology
Adenocarcinoma*/genetics
Aspartate-tRNA Ligase*/metabolism
Animals ; Mice ; Humans ; Mice, Nude ; Proto-Oncogene Proteins c-myc/genetics ; Proto-Oncogene Proteins c-myc/metabolism ; Signal Transduction ; Cell Line, Tumor ; Cell Proliferation ; Cell Movement ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1.
Autorzy:
Xu R; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Lee YJ; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Kim CH; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Min GH; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Kim YB; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Park JW; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Kim DH; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea.
Kim JH; Division of Intractable Diseases Research, Department of Chronic Diseases Convergence Research, Korea National Institute of Health, Cheongju, Chungcheongbuk-Do, 28160, Republic of Korea.
Yim H; Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-Do, 15588, Republic of Korea. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Nov 16; Vol. 42 (1), pp. 302. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*
Lung Neoplasms*/genetics
Animals ; Mice ; Humans ; Forkhead Transcription Factors/metabolism ; Forkhead Box Protein M1/genetics ; Tumor-Associated Macrophages/metabolism ; Chromatography, Liquid ; Tandem Mass Spectrometry ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Stemness genes and miR-1247-3p expression associate with clinicopathological parameters and prognosis in lung adenocarcinoma.
Autorzy:
Limbu S; Quantitative and System Biology Program, University of California, Merced, Merced, CA, United States of America.
McCloskey KE; Quantitative and System Biology Program, University of California, Merced, Merced, CA, United States of America.; Materials Science and Engineering Department, University of California, Merced, Merced, CA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Nov 10; Vol. 18 (11), pp. e0294171. Date of Electronic Publication: 2023 Nov 10 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma of Lung*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Adenocarcinoma*/pathology
Humans ; Prognosis
Czasopismo naukowe
Tytuł:
DDX52 gene expression in LUAD tissues indicates potential as a prognostic biomarker and therapeutic target.
Autorzy:
Xu M; Department of Thoracic Surgery, Affiliated Hospital of Nantong University, 20 Xisi Street, Nantong, 226001, China.
Yang M; Department of Thoracic Surgery, Affiliated Hospital of Nantong University, 20 Xisi Street, Nantong, 226001, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Oct 13; Vol. 13 (1), pp. 17434. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*
Adenocarcinoma*
Lung Neoplasms*
Humans ; Prognosis ; RNA Helicases ; DNA Helicases ; Gene Expression ; Biomarkers
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies